ECSP088455A - Nuevos derivados de indolizina, su proceso de preparación y las composiciones terapéuticas que los comprenden - Google Patents
Nuevos derivados de indolizina, su proceso de preparación y las composiciones terapéuticas que los comprendenInfo
- Publication number
- ECSP088455A ECSP088455A EC2008008455A ECSP088455A ECSP088455A EC SP088455 A ECSP088455 A EC SP088455A EC 2008008455 A EC2008008455 A EC 2008008455A EC SP088455 A ECSP088455 A EC SP088455A EC SP088455 A ECSP088455 A EC SP088455A
- Authority
- EC
- Ecuador
- Prior art keywords
- alkyl radical
- cyclic
- branched
- linear
- radical
- Prior art date
Links
- HOBCFUWDNJPFHB-UHFFFAOYSA-N indolizine Chemical class C1=CC=CN2C=CC=C21 HOBCFUWDNJPFHB-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000003406 indolizinyl group Chemical class C=1(C=CN2C=CC=CC12)* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Derivados de indolizina de fórmula general (I) en la que, X representa un radical -(CH2)n- siendo n un número entero que va de 1 a 6, o un grupo de fórmula CH2-Z-(CH2)2-, en la que Z representa un grupo O(CH2)m- en la que m es un número entero que va de 0 a 3, R1 representa un radical alquilo C1-C8 lineal, ramificado o cíclico; Am representa un grupo NR3R4 en el que R3 y R4 son idénticos o diferentes y representan de manera independiente el uno del otro - un átomo de hidrógeno, - un radical alquilo C1-C6 lineal, ramificado o cíclico, o C1-C3 sustituido con un radical cicloalquilo C3-C6, - o un radical (CH2)l-O-B, en el que B representa un átomo de hidrógeno o un radical alquilo (CH2)k, siendo l y k números enteros l ³ 2 y l+k £ 6 o R3 y R4 forman junto al átomo de nitrógeno al que están unidos un heterociclo de 4 a 6 eslabones que puede contener opcionalmente uno o varios heteroátomos elegidos entre N y O y que contiene opcionalmente uno o varios sustituyentes elegidos entre un radical alquilo C1-C6 lineal, ramificado o cíclico, R2 representa un átomo de hidrógeno o un radical alquilo C1-C6 lineal, ramificado o cíclico, y sus sales aceptables desde un punto de vista farmacéutico.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0511849A FR2893616B1 (fr) | 2005-11-23 | 2005-11-23 | Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant |
| PCT/FR2006/002551 WO2007060318A1 (fr) | 2005-11-23 | 2006-11-21 | Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP088455A true ECSP088455A (es) | 2008-06-30 |
Family
ID=37027751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2008008455A ECSP088455A (es) | 2005-11-23 | 2008-05-16 | Nuevos derivados de indolizina, su proceso de preparación y las composiciones terapéuticas que los comprenden |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US7799799B2 (es) |
| EP (1) | EP1957490B1 (es) |
| JP (1) | JP5372514B2 (es) |
| KR (1) | KR101419066B1 (es) |
| CN (1) | CN101312973B (es) |
| AR (1) | AR058208A1 (es) |
| AT (1) | ATE454386T1 (es) |
| AU (1) | AU2006316381B2 (es) |
| BR (1) | BRPI0618975A2 (es) |
| CA (1) | CA2629738C (es) |
| CR (1) | CR9927A (es) |
| CY (1) | CY1110623T1 (es) |
| DE (1) | DE602006011649D1 (es) |
| DK (1) | DK1957490T3 (es) |
| DO (1) | DOP2006000254A (es) |
| EA (1) | EA014158B1 (es) |
| EC (1) | ECSP088455A (es) |
| ES (1) | ES2338922T3 (es) |
| FR (1) | FR2893616B1 (es) |
| GT (1) | GT200600489A (es) |
| HR (1) | HRP20100158T1 (es) |
| IL (1) | IL190861A (es) |
| MA (1) | MA30055B1 (es) |
| NO (1) | NO20082589L (es) |
| PE (1) | PE20071083A1 (es) |
| PL (1) | PL1957490T3 (es) |
| PT (1) | PT1957490E (es) |
| SI (1) | SI1957490T1 (es) |
| TN (1) | TNSN08162A1 (es) |
| TW (1) | TW200738705A (es) |
| UY (1) | UY29965A1 (es) |
| WO (1) | WO2007060318A1 (es) |
| ZA (1) | ZA200803565B (es) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8759344B2 (en) | 2010-07-06 | 2014-06-24 | Sanofi | Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2893616B1 (fr) | 2005-11-23 | 2008-01-04 | Sanofi Aventis Sa | Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant |
| FR2962438B1 (fr) | 2010-07-06 | 2012-08-17 | Sanofi Aventis | Derives d'indolizines, procedes de preparation et application en therapeutique |
| CN103360390B (zh) * | 2013-07-23 | 2015-06-17 | 东南大学 | 中氮茚甲酰甲基对甲磺酰胺苯乙胺衍生物及其医药用途 |
| CN110156776A (zh) * | 2019-04-30 | 2019-08-23 | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 一种c-3芳甲酰基吲嗪类化合物的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI61030C (fi) * | 1976-02-19 | 1982-05-10 | Sanofi Sa | Foerfarande foer framstaellning av terapeutiskt verkande 2-substituerade-1- eller 3-benzoyl-indolizinderivat |
| FR2665444B1 (fr) * | 1990-08-06 | 1992-11-27 | Sanofi Sa | Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant. |
| US5334716A (en) * | 1991-06-17 | 1994-08-02 | Fujisawa Pharmaceutical Co., Ltd. | Heterocyclic derivatives |
| US6593322B1 (en) * | 1999-03-17 | 2003-07-15 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
| FR2813306B1 (fr) * | 2000-08-23 | 2005-10-21 | Sanofi Synthelabo | Aminoalkybenzoyl-benzofurannes ou benzothiophenes, leur procede de preparation et les compositions les contenant |
| FR2893616B1 (fr) | 2005-11-23 | 2008-01-04 | Sanofi Aventis Sa | Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant |
-
2005
- 2005-11-23 FR FR0511849A patent/FR2893616B1/fr not_active Expired - Fee Related
-
2006
- 2006-11-15 DO DO2006000254A patent/DOP2006000254A/es unknown
- 2006-11-20 GT GT200600489A patent/GT200600489A/es unknown
- 2006-11-20 PE PE2006001477A patent/PE20071083A1/es not_active Application Discontinuation
- 2006-11-21 AR ARP060105086A patent/AR058208A1/es not_active Application Discontinuation
- 2006-11-21 DK DK06831144.8T patent/DK1957490T3/da active
- 2006-11-21 AT AT06831144T patent/ATE454386T1/de active
- 2006-11-21 EA EA200801400A patent/EA014158B1/ru not_active IP Right Cessation
- 2006-11-21 TW TW095143038A patent/TW200738705A/zh unknown
- 2006-11-21 CA CA2629738A patent/CA2629738C/fr not_active Expired - Fee Related
- 2006-11-21 SI SI200630601T patent/SI1957490T1/sl unknown
- 2006-11-21 PT PT06831144T patent/PT1957490E/pt unknown
- 2006-11-21 ZA ZA200803565A patent/ZA200803565B/xx unknown
- 2006-11-21 WO PCT/FR2006/002551 patent/WO2007060318A1/fr not_active Ceased
- 2006-11-21 DE DE602006011649T patent/DE602006011649D1/de active Active
- 2006-11-21 JP JP2008541787A patent/JP5372514B2/ja not_active Expired - Fee Related
- 2006-11-21 PL PL06831144T patent/PL1957490T3/pl unknown
- 2006-11-21 EP EP06831144A patent/EP1957490B1/fr active Active
- 2006-11-21 BR BRPI0618975-0A patent/BRPI0618975A2/pt not_active IP Right Cessation
- 2006-11-21 CN CN2006800437271A patent/CN101312973B/zh not_active Expired - Fee Related
- 2006-11-21 HR HR20100158T patent/HRP20100158T1/hr unknown
- 2006-11-21 KR KR1020087012214A patent/KR101419066B1/ko not_active Expired - Fee Related
- 2006-11-21 ES ES06831144T patent/ES2338922T3/es active Active
- 2006-11-21 AU AU2006316381A patent/AU2006316381B2/en not_active Ceased
- 2006-11-23 UY UY29965A patent/UY29965A1/es unknown
-
2008
- 2008-04-10 TN TNP2008000162A patent/TNSN08162A1/en unknown
- 2008-04-14 IL IL190861A patent/IL190861A/en not_active IP Right Cessation
- 2008-04-25 CR CR9927A patent/CR9927A/es not_active Application Discontinuation
- 2008-05-08 US US12/116,996 patent/US7799799B2/en not_active Expired - Fee Related
- 2008-05-16 EC EC2008008455A patent/ECSP088455A/es unknown
- 2008-06-10 NO NO20082589A patent/NO20082589L/no not_active Application Discontinuation
- 2008-06-16 MA MA31037A patent/MA30055B1/fr unknown
-
2010
- 2010-03-31 CY CY20101100303T patent/CY1110623T1/el unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8759344B2 (en) | 2010-07-06 | 2014-06-24 | Sanofi | Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof |
| US9452164B2 (en) | 2010-07-06 | 2016-09-27 | Sanofi | Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2019003239A1 (es) | Amidas de piridona deuteradas y profármacos de los mismos como moduladores de canales de sodio. | |
| AR068055A1 (es) | Derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol su procedimiento de preparacion su aplicacion como medicamentos composiciones farmaceuticas y su utilizacion principalmente como inhibidores de met | |
| AR106943A2 (es) | Compuestos de isoindolina y composiciones farmacéuticas de los mismos | |
| CO4970728A1 (es) | 2-aminopiridinas que contienen sustituyentes de anillos condensados | |
| AR062928A1 (es) | Inhibidores de la actividad quinasa utiles en el tratamiento de trastornos mediados por mecanismos de ikk2 | |
| AR044909A1 (es) | Derivados de tiazolilpiperidina, procesos para su preparacion, composiciones farmaceuticas que los comprenden y aplicaciones de dichos derivados en el tratamiento de hipertrigliceridemia , hipercolesterolemia y dislipidemia | |
| AR083026A1 (es) | Derivados de ciclohexenona y composiciones para el tratamiento del cancer de pulmon | |
| ES2631611T3 (es) | Amidas de piperidina de Pirano-Espirociclico como moduladores de canales iónicos | |
| AR059314A1 (es) | Derivados de las benzamidas y heteroarenos | |
| PE20090111A1 (es) | Derivados de bencimidazol | |
| AR072798A1 (es) | Derivados de pirido-piridinonas, su preparacion, composicion farmaceutica y su uso en el tratamiento de las enfermedades ligadas a la actividad de la proteina quinasa | |
| CO5631432A2 (es) | Derivados de n-[fenil(piepidin-2-il)metil]benzamida, su preparacion y su aplicacion en terapeutica | |
| CO4810298A1 (es) | Nuevas amidas aromaticas y su procedimiento de preparacion . | |
| PA8795301A1 (es) | Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen | |
| ECSP099682A (es) | Nuevos compuestos heterociclicos nitrogenados, su preparación y su utilización como medicamentos antibacterianos | |
| CO6320143A1 (es) | Nuevos derivados dihidroindolonas su procedimeinto de preparacion y composiciones farmaceuticas que los contienen | |
| PE20070097A1 (es) | Agonistas del receptor de niacina y composiciones que contienen tales compuestos | |
| CO6230990A2 (es) | Nuevos derivados triciclicos su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| AR066605A1 (es) | Derivados de heteroarilamida pirimidona | |
| AR053149A1 (es) | Uso de compuestos de diosmetina para la obtencion de composiciones farmaceuticas destinadas a la prevencion y/o tratamiento de patologias tromboticas y patologias que conlleven el riesgo de producir trombosis | |
| CR9499A (es) | Nuevos derivados de fenilpiridinilpiperazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| DOP2006000254A (es) | Nuevos derivados de indolizina, su proceso de preparación y las composiciones terapéuticas que los comprenden | |
| AR054341A1 (es) | Combinaciones sinergicas de compuestos activos fungicidas | |
| AR054747A1 (es) | Compuestos de indanil-piperazina un procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| CO5200761A1 (es) | Nuevos derivados de equinocandina, su procedimiento de preparacion y su aplicacion como antifungicos |